مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

15
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

9
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Identification of TMEM178 as a Potential Prognostic Biomarker and Therapeutic Target for Breast Cancer

Pages

  2427-2439

Abstract

 Background: The transmembrane protein (TMEM) family plays important roles in cancer. However, the expression pattern and biological roles of TMEM178, a member of TMEM family, remains unclear in breast cancer (BRCA). Methods: Methylation and RNA-seq data were obtained to explore methylation level. Expression of TMEM178, methylation inhibitor 5-Aza-CdR was used to verify the effect of methylation status on the expression of TMEM178. We comprehensively investigated the prognostic outcomes, biological functions and effects on immune cell infiltration of the TMEM178 in BRCA using multiple bioinformatics methods. Results: The expression of TMEM178 was downregulated and negatively correlated with the level of DNA methylation and DNA methyltransferase (DNMT1, DNMT3A, and DNMT3B) in BRCA. Consistently, TMEM178 mRNA were confirmed to be downregulated, while upregulated in response to treatment with methylation inhibitor 5-Aza-CdR by RT-qPCR. Patients with high expression of TMEM178 have better prognosis and are more sensitive to targeted drug Pazopanib. Immune infiltration analysis showed that the infiltration levels of CD4 + T cell subsets were reduced in BRAC tissues with high TMEM178 expression, and Immunosuppressive molecules of T-cell exhaustion were lower expression level. Conclusion: Hypermethylation of the TMEM178 promoter region was a contributing factor to the downregulation of its expression, and TMEM178 may reflect a prognostic and immunosuppressive situation in BRCA.

Cites

  • No record.

    • References

    Cite

    APA: Copy

    Yan, Jiaoyan, Yang, Ye, Lu, Jingrun, Yuan, Yan, Wu, Xiangyi, HUANG, JIAN, & Zhang, Shu. (2023). Identification of TMEM178 as a Potential Prognostic Biomarker and Therapeutic Target for Breast Cancer. IRANIAN JOURNAL OF PUBLIC HEALTH, 52(11), 2427-2439. SID. https://sid.ir/paper/1101160/en

    Vancouver: Copy

    Yan Jiaoyan, Yang Ye, Lu Jingrun, Yuan Yan, Wu Xiangyi, HUANG JIAN, Zhang Shu. Identification of TMEM178 as a Potential Prognostic Biomarker and Therapeutic Target for Breast Cancer. IRANIAN JOURNAL OF PUBLIC HEALTH[Internet]. 2023;52(11):2427-2439. Available from: https://sid.ir/paper/1101160/en

    IEEE: Copy

    Jiaoyan Yan, Ye Yang, Jingrun Lu, Yan Yuan, Xiangyi Wu, JIAN HUANG, and Shu Zhang, “Identification of TMEM178 as a Potential Prognostic Biomarker and Therapeutic Target for Breast Cancer,” IRANIAN JOURNAL OF PUBLIC HEALTH, vol. 52, no. 11, pp. 2427–2439, 2023, [Online]. Available: https://sid.ir/paper/1101160/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button